Sarepta Soars After Positive Results In DMD Treatment Study By: Benzinga via Benzinga September 06, 2017 at 13:35 PM EDT Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are trading higher by $5.75, or 14 percent, at $46.83 in Wednesday's session. The ... Read More >> Related Stocks: Sarepta Therapeutics